Marsha Fanucci - 08 Jun 2022 Form 4 Insider Report for Forma Therapeutics Holdings, Inc. (FMTX)

Role: Director
Signature: /s/ Jeannette Potts, as Attorney-in-Fact
Issuer symbol: FMTX
Transactions as of: 08 Jun 2022
Transactions value $: $0
Form type: 4
Filing time: 09 Jun 2022, 17:31:49 UTC
Previous filing: 02 Jun 2022
Next filing: 16 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FMTX	Common Stock	Award	$0	+4.5K	+8.14%	$0.00	59.8K	08 Jun 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FMTX	Stock Option (Right to Buy)	Award	$0	+6.75K		$0.00	6.75K	08 Jun 2022	Common Stock	6.75K	$6.12	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units and will be settled into common stock upon vesting. Each restricted stock unit would be converted into one share of FMTX common stock.
F2	This option shall vest and become exercisable in full upon the earlier to occur of (i) June 8, 2023 and (ii) the next annual meeting of the Issuer's stockholders.